Introducing FUTURE-AI: Best practices for trustworthy AI in medical imaging

Published on: February 16, 2022
Categories: News

ProCAncer -I Project is part of the five H2020 projects that share the same vision, principles and challenges. These projects are funded under the same Action Line: AI for Health Imaging (Call: H2020-SC1-FA-DTS-2019-1): CHAIMELEON (chaimeleon.eu), EuCanImage (eucanimage.eu), INCISIVE (incisive-project.eu) and PRIMAGE (primageproject.eu). We believe that AI in medical imaging will achieve its full potential only once it has gained the trust of clinicians, patients, and policymakers, so we have established the FUTURE – AI initiative.

Taking part in the FUTURE – AI initiative will help build the trust among all interested parties. What is FUTURE-AI? It is an international, multi-stakeholder initiative for defining and maintaining concrete guidelines that will facilitate the design, development, validation and deployment of trustworthy AI solutions in medical imaging based on six guiding principles: Fairness, Universality, Traceability, Usability, Robustness and Explainability.

The FUTURE-AI assessment checklist consists of concrete and actionable questions that will guide developers, evaluators and other stakeholders in delivering imaging AI tools that are trustworthy and optimised for real-world practice. Each element of the FUTURE-AI checklist is provided with examples to illustrate potential mitigation measures for minimising the risks of imaging AI algorithms based on the FUTURE-AI guiding principles. While not all questions of the FUTURE-AI checklist are applicable in every application and scenario, we encourage the AI teams to build on as many elements as possible to produce imaging AI algorithms with solid foundations towards their trustworthiness and adoption.

The initiative has the potential to provide long-term foundations for regulators to build on in the future. What does this mean? It means that organizations, regulators, individuals, governments and healthcare organizations will have a reliable source of tools that are trustworthy and optimised regarding health imaging AI tools, and alongside improve the healthcare for all people around the world

LEARN MORE

 

 

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Stay in touch!